Cargando…
Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy
Combination therapies constitute a powerful tool for cancer treatment. By combining drugs with different mechanisms of action, the limitations of each individual agent can be overcome, while increasing therapeutic benefit. Here, we propose employing tumor-migrating decidua-derived mesenchymal stroma...
Autores principales: | de la Torre, Paz, Paris, Juan L., Fernández-de la Torre, Miguel, Vallet-Regí, María, Flores, Ana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916487/ https://www.ncbi.nlm.nih.gov/pubmed/33578733 http://dx.doi.org/10.3390/pharmaceutics13020244 |
Ejemplares similares
-
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
por: Paris, Juan L., et al.
Publicado: (2020) -
Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
por: Baeza, Alejandro, et al.
Publicado: (2020) -
Functional Mesoporous Silica Nanocomposites: Biomedical Applications and Biosafety
por: Castillo, Rafael R., et al.
Publicado: (2019) -
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
por: Castillo, Rafael R., et al.
Publicado: (2020) -
Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles
por: Gisbert-Garzarán, Miguel, et al.
Publicado: (2020)